Albuterol-budesonide pressurized metered dose inhaler in patients with mild-to-moderate asthma: results of the DENALI double-blind randomized controlled trial.

Bradley E Chipps,Elliot Israel,Richard Beasley,Reynold A Panettieri,Frank C Albers,Robert Rees, Lynn Dunsire, Anna Danilewicz,Eva Johnsson,Christy Cappelletti,Alberto Papi

Chest（2023）

引用 0|浏览1

暂无评分

摘要

Both mono-components contributed to albuterol-budesonide lung function efficacy. Albuterol-budesonide was well-tolerated, even at regular relatively high daily doses for 12 weeks, with no new safety findings, supporting its use as a novel rescue therapy.

查看译文

关键词

albuterol-ICS,albuterol–budesonide,asthma,bronchodilators,inflammation,inhaled corticosteroid,rescue therapy,short-acting β(2)-agonist

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要